🏢 What kind of company is UFP Technologies?

UFP Technologies (UFPT) is a US medical device component manufacturer that produces custom components and single-use products for the medical device industry. The company designs, manufactures, and supplies custom single-use medical components and packaging, as well as specialty foam components, tailored to medical device companies' specifications, and has built its position through contract manufacturing solutions that are integrated into customer medical device programs.

Its core business is contract manufacturing of custom components and single-use products for medical devices. The company designs and manufactures custom single-use medical components and packaging, as well as specialty foam components, to medical device companies' specifications and provides solutions integrated into customer medical device programs, while expanding its medical device component business through acquisitions.

💰 How does UFP Technologies make money?

Business segment	Revenue mix	Description
Single-use medical components	Core business	Custom single-use medical components
Medical packaging and foam	Key growth driver	Medical packaging and specialty foam components
Acquisitions and customer programs	Diversification driver	Expansion through acquisitions and customer programs

Single-use medical components form the core of revenue, while medical packaging and foam components, along with customer program expansion, contribute to revenue growth. Revenue is tied to medical device demand, customer programs, and acquisitions, and recurring demand for single-use medical components adds stability. Medical device demand, customer program expansion, acquisitions, and profitability improvement will be the key drivers of future earnings.

📐 Market cap and corporate scale of UFP Technologies

Market capitalization stands at $2.0B, with 4,846명 employees.

UFP Technologies is a mid-sized medical device component company that highlights its custom medical component manufacturing capabilities, customer program integration, and acquisition-led growth as competitive strengths. While it shares aspects of its operating environment with fellow medical device players IART, GMED, and PEN, it pursues differentiation through its specialization in contract manufacturing of custom components for medical devices. The company is in a phase of pursuing growth by focusing its resources on acquisitions and customer program expansion.

📈 UFP Technologies outlook and stock performance

📊 최근 1년 주가흐름

🎯 애널리스트 컨센서스

2.0

매도 보유 적극 매수

목표가 $325 +27.4% 현재 $255

📏 52주 가격 범위

$255

최저 $174 최고 $279

최저 대비 +46.54% 최고 대비 -8.84%

Increasing medical device demand, growing demand for single-use medical products, customer program expansion, and acquisitions are the key medium- to long-term growth drivers. An aging population and rising medical demand underpin structural demand for single-use medical components, while customer program integration and acquisitions drive growth. In the short term, changes in medical device demand, customer program schedules, costs and supply chain, acquisition integration expenses, and intensifying competition could act as sources of volatility in earnings and the stock price.

• Increasing medical device demand and demand for single-use medical products
• Customer program expansion and integration
• Business expansion through acquisitions

⚔️ UFP Technologies core strengths and risks

Custom medical component manufacturing capabilities, customer program integration, and recurring demand for single-use products are strengths, while medical device demand, customer programs, and acquisition integration are the key risks.

💪 Core strengths

Custom manufacturing capabilities

The company possesses manufacturing capabilities for custom medical components tailored to medical device specifications.

Customer program integration

Integration into customer medical device programs creates high switching costs.

Recurring demand

Recurring demand for single-use medical components supports stable revenue.

⚠️ Key risks

Medical device demand

Changes in medical device demand and customer program schedules affect revenue.

Costs and supply chain

Cost and supply chain fluctuations affect margins.

Acquisitions and competition

Acquisition integration costs and intensifying competition in medical device components are risk factors.

🔄 UFP Technologies competitors and related (beneficiary) stocks

Direct competitors often grouped within the same medical device space include surgical and regenerative medical device maker IART, medical robotics and device company GMED, and thrombectomy and interventional medical device company PEN. Related stocks grouped together include large-cap medical device companies BSX and MDT, and surgical robotics company ISRG, with trends in the medical device industry linking to UFPT's operating environment.

⚔️ 경쟁주

종목	회사명	가격	등락	시총	PER	PBR	ROE	배당률
IART	Integra Lifesciences Holdings Corp	$16.65	-2.8%	$1.3B	-	1.2	-0.7%	-
GMED	Globus Medical Inc	$78.79	-1.8%	$10.7B	18.4	2.3	13.3%	-
PEN	Penumbra Inc	$321.19	+0.4%	$12.6B	78.9	8.3	11.37%	-

✅ Investor checklist for UFP Technologies

Here are key points to review when investing in UFP Technologies. Medical device demand, customer programs, and acquisitions are the key short-term variables, and it is also necessary to monitor costs and supply chain, profitability, and the intensity of competition.

Changes in medical device demand and customer program schedules could affect revenue. Cost and supply chain fluctuations could affect margins, while acquisition integration expenses and intensifying competition in medical device components could also act as sources of stock price volatility.

As a medical device component company specialized in custom components and single-use products for medical devices, steady growth is expected from rising medical device demand, expansion of customer programs, and growth through acquisitions. However, given that the stock is affected by medical device demand, customer programs, and acquisition integration, dollar-cost averaging and a long-term perspective are recommended.